Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis

Angiology

Volumn 50, Issue 10, 1999, Pages 781-787

  Belcaro, G ^a   Nicolaides, A N ^a   Cesarone, M R ^a   Laurora, G ^a   De Sanctis, M T ^a   Incandela, L ^a   Barsotti, A ^a   Corsi, M ^a   Vasdekis, S ^a   Christopoulos, D ^a   Lennox, A ^a   Malouf, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HEPARIN CALCIUM; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL STANDARD UNIT; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032860918     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905001001     Document Type: Article

References (12)

1. Levine M, Gent M, Hirsh J, et al: A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334:677-681, 1996.
2. Belcaro G, Nicolaides AN, Stansby G: The Venous Clinic. London: Imperial College Press, 1988.
3. Thomas DG, Gart JJ: A table of exact confidence limits for differences and ratios of two proportions and their odds ratios. JAMA 72:73-76, 1977.
4. Largerstedt CI, Olsson CG, Fagher BO, et al: Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515-518, 1985.
5. Brandjes DPM, Heijboer H, Buller HR, et al: Acenocumarol and heparin compared with acenocumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 327:1485-1489, 1992.
6. Hull RD, Pineo GF: Low-molecular-weight-heparin in treatment of venous thromboembolism. Int Angiol 17:131-134, 1998.
7. Hull RD, Raskob GE, Pineo GF, et al: Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 326:975-982, 1992.
8. Lensing AW, Prins MH, Davidson BL, et al: Treatment of deep venous thrombosis with low-molecular-weight-heparins: A meta-analysis. Arch Intern Med 155:601-607, 1995.
9. Pini A, Aiello S, Manotti C, et al: Low-molecular-weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 72:191-197, 1994.
10. Prandoni P, Lensing AW, Buller HR, et al: Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deepvein thrombosis. Lancet 339:441-445, 1992.
11. Hirsh RD, Levine MN: Low-molecular-weight heparin. Blood 79:1-7, 1992.
12. Monreal M, Lafoz E, Olive A, et al: Comparison of subcutaneous unfractionated heparin with a low-molecular-weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 71:7-11, 1994.